Drs Nunnery and Nguyen discuss the emergence of the oral SERD giredestrant in hormone receptor–positive, HER2-negative breast cancer management.
MinhTri Nguyen, MD
Advertisement
MinhTri Nguyen, MD, is a breast medical oncologist, assistant professor, and lead faculty for Health Equity at Rush MD Anderson Cancer Center
Articles by MinhTri Nguyen, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Epcoritamab Plus Lenalidomide/Rituximab Win EU Approval for R/R Follicular Lymphoma
2
FDA Issues CRL to Orviglance for Liver Metastasis Imaging in Patients With Severe Kidney Impairment
3
Adagrasib Plus Cetuximab Misses OS, PFS End Points in Pretreated KRAS G12C–Mutated CRC
4
Savolitinib Gains NMPA Approval for MET-Amplified Gastric and GEJ Adenocarcinoma
5